US2015132249A1PendingUtilityA1
Stimuli responsive polyester amide particles
Assignee: ABBOTT CARDIOVASCULAR SYSTEMSPriority: Aug 30, 2006Filed: Jan 6, 2015Published: May 14, 2015
Est. expiryAug 30, 2026(~0.1 yrs left)· nominal 20-yr term from priority
A61K 47/48207C08G 69/44A61K 31/436A61K 9/0019Y10S977/906A61L 24/001A61K 47/595A61L 24/046A61L 2430/36
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A composition including a solution suitable for introduction into a blood vessel comprising particles including a treatment agent and a tunable stimuli-responsive polymer. A method including introducing a delivery device into a blood vessel; and introducing a solution into the blood vessel, the solution including particles comprising a treatment agent and a tunable stimuli-responsive polymer. A method including combining a treatment agent and a tunable stimuli-responsive polymer; and forming particles of the combination suitable for delivery through a blood vessel.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method comprising:
introducing a solution through a delivery device into a blood vessel, wherein the solution comprises particles comprising a treatment agent and a tunable stimuli-responsive polymer.
2 . The method of claim 1 wherein the stimuli-responsive polymer comprises a polymer responsive to at least one of a physiochemical and a pharmacochemical stimulus.
3 . The method of claim 1 wherein the polymer comprises an amino acid backbone.
4 . The method of claim 3 wherein the polymer comprises a polyester amide.
5 . The method of claim 3 wherein the polymer comprises a backbone comprising an amino acid, a diol, and a diacid.
6 . The method of claim 3 wherein the treatment agent comprises one of an anti-inflammatory agent and an anti-proliferative agent.
7 . The method of claim 1 wherein the delivery device comprises a percutaneously inserted transluminal catheter and introducing a solution through the delivery device comprises introducing the catheter to a treatment site.
8 . A method comprising:
combining a treatment agent and a tunable stimuli-responsive polymer; and forming particles of the combination suitable for delivery through a blood vessel.
9 . The method of claim 8 , wherein the particles comprise nanoparticles.
10 . The method of claim 9 wherein the polymer comprises a polyester amide.
11 . The method of claim 8 wherein combining comprises conjugating the treatment agent to the polymer.
12 . The method of claim 8 wherein the particles comprise a treatment agent with multiple layers of the polymer.
13 . The method of claim 8 wherein the polymer further comprises a hydrophilic diamine or diol conjugated to the polymer.
14 . A composition comprising:
a solution suitable for introduction into a blood vessel having particles comprising a treatment agent and a stimuli-responsive polymer, the stimuli-responsive polymer having a backbone comprising an amino acid, a diol and a diacid and wherein a hydrophilic diamine or diol is conjugated to the polymer.
15 . The composition of claim 14 wherein the amino acid is a first amino acid, the composition further comprising:
a second amino acid.
16 . The composition of claim 15 wherein the first amino acid is lysine and the second amino acid is cysteine.
17 . The composition of claim 14 wherein the treatment agent is conjugated to the backbone.Join the waitlist — get patent alerts
Track US2015132249A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.